Search Results - "DUNKEL, I"

Advanced ADC Histogram, Perfusion, and Permeability Metrics Show an Association with Survival and Pseudoprogression in Newly Diagnosed Diffuse Intrinsic Pontine Glioma: A Report from the Pediatric Brain Tumor Consortium by Vajapeyam, S, Brown, D, Billups, C, Patay, Z, Vezina, G, Shiroishi, M S, Law, M, Baxter, P, Onar-Thomas, A, Fangusaro, J R, Dunkel, I J, Poussaint, T Y

“…Diffuse intrinsic pontine glioma is a lethal childhood brain cancer with dismal prognosis and MR imaging is the primary methodology used for diagnosis and…”
Get full text

Intra-Arterial Chemotherapy as a Treatment for Intraocular Retinoblastoma: Alternatives to Direct Ophthalmic Artery Catheterization by KLUFAS, M. A, GOBIN, Y. P, MARR, B, BRODIE, S. E, DUNKEL, I. J, ABRAMSON, D. H

“…Intra-arterial chemotherapy is a very effective treatment option for intraocular retinoblastoma. However, direct catheterization of the OA is not always…”
Get full text

ADC Histogram Analysis of Pediatric Low-Grade Glioma Treated with Selumetinib: A Report from the Pediatric Brain Tumor Consortium by Vajapeyam, S, Brown, D, Ziaei, A, Wu, S, Vezina, G, Stern, J S, Panigrahy, A, Patay, Z, Tamrazi, B, Jones, J Y, Haque, S S, Enterline, D S, Cha, S, Jones, B V, Yeom, K W, Onar-Thomas, A, Dunkel, I J, Fouladi, M, Fangusaro, J R, Poussaint, T Y

“…Selumetinib is a promising MAP (mitogen-activated protein) kinase (MEK) 1/2 inhibitor treatment for pediatric low-grade gliomas. We hypothesized that MR…”
Get full text

Retinoblastoma patients with high risk ocular pathological features: who needs adjuvant therapy? by Chantada, G L, Dunkel, I J, de Dávila, M T G, Abramson, D H

“…Aims: To describe the outcome of patients with non-metastatic unilateral retinoblastoma with high risk histopathological features after primary enucleation,…”
Get full text

The measurement of symptoms in children with cancer by COLLINS, J. J, BYRNES, M. E, DUNKEL, I. J, LAPIN, J, NADEL, T, THALER, H. T, POLYAK, T, RAPKIN, B, PORTENOY, R. K

“…The purpose of this study was to determine symptom prevalence, characteristics, and distress in children with cancer. The Memorial Symptom Assessment Scale…”
Get full text

Psychiatric manifestations as initial presentation for pediatric CNS germ cell tumors, a case series by Malbari, F., Gershon, T. R., Garvin, J. H., Allen, J. C., Khakoo, Y., Levy, A. S., Dunkel, I. J.

“…Background Central nervous system (CNS) germ cell tumors account for 3 % of all pediatric brain tumors in the USA. Presenting symptoms are typically location…”
Get full text

Orbital recurrence of retinoblastoma following enucleation by Kim, J W, Kathpalia, V, Dunkel, I J, Wong, R K, Riedel, E, Abramson, D H

“…To determine the incidence, clinical presentation and histopathological profile of patients developing orbital recurrence following enucleation for…”
Get more information

Craniospinal Radiation Therapy May Not Be Necessary for Localized Nongerminomatous Germ Cell Tumors (NGGCT) by Cahlon, O, Dunkel, I, Gilheeney, S, Khakoo, Y, Souweidane, M, De Braganca, K, Kramer, K, Wolden, S

Get full text

A phase I/II study of subconjunctival carboplatin for intraocular retinoblastoma by Abramson, D H, Frank, C M, Dunkel, I J

“…To evaluate the efficacy and toxicity of subconjunctival carboplatin for intraocular retinoblastoma. A phase I/II clinical trial (noncomparative case series)…”
Get more information

Longitudinal MR Spectroscopic Imaging of Pediatric Diffuse Pontine Tumors to Assess Tumor Aggression and Progression by Thakur, S.B, Karimi, S, Dunkel, I.J, Koutcher, J.A, Huang, W

“…Two pediatric patients with diffuse pontine tumors underwent MR spectroscopic imaging pre- and postradiation. Choline/creatine (Cho/Cr) and…”
Get full text

Presenting signs of retinoblastoma by Abramson, David H., Frank, Christopher M., Susman, Mark, Whalen, Mary P., Dunkel, Ira J., Boyd, Norman W.

“…A retrospective chart review was performed on the charts of 1265 patients with retinoblastoma who were on file at New York Hospital and whose conditions had…”
Get full text

Intensive chemotherapy and bone marrow rescue for young children with newly diagnosed malignant brain tumors by Mason, W P, Grovas, A, Halpern, S, Dunkel, I J, Garvin, J, Heller, G, Rosenblum, M, Gardner, S, Lyden, D, Sands, S, Puccetti, D, Lindsley, K, Merchant, T E, O'Malley, B, Bayer, L, Petriccione, M M, Allen, J, Finlay, J L

“…To evaluate a strategy that avoids radiotherapy in children less than 6 years of age with newly diagnosed malignant brain tumors, by administering…”
Get more information

Delayed Diagnosis of Retinoblastoma: Analysis of Degree, Cause, and Potential Consequences by Butros, Linda J, Abramson, David H, Dunkel, Ira J

“…To assess the degree, cause, and consequence of delays from presenting signs to diagnosis of retinoblastoma. A retrospective chart review was conducted of 64…”
Get full text

Systemic carboplatin for retinoblastoma: change in tumour size over time by Abramson, D H, Lawrence, S D, Beaverson, K L, Lee, T C, Rollins, I S, Dunkel, I J

“…Background/aim: Chemotherapy for intraocular retinoblastoma is used to shrink individual retinal tumours to a size amenable to focal treatments. Quantitative…”
Get full text

A Retrospective Study of Re-irradiation (Re-RT) for Recurrent Medulloblastoma (MB) by Bakst, R.L, Dunkel, I, Gilheeney, S, Khakoo, Y, Becher, O, Souweidane, M, Wolden, S

Get full text

Myeloablative chemotherapy with autologous bone marrow rescue in young children with recurrent malignant brain tumors by Guruangan, S, Dunkel, I J, Goldman, S, Garvin, J H, Rosenblum, M, Boyett, J M, Gardner, S, Merchant, T E, Gollamudi, S, Finlay, J L

“…This study evaluates the outcome of myeloablative chemotherapy and autologous bone marrow rescue (ABMR) with or without radiotherapy in children younger than 6…”
Get more information

Transdermal fentanyl in children with cancer pain: Feasibility, tolerability, and pharmacokinetic correlates by Collins, John J., Dunkel, Ira J., Gupta, Suneel K., Inturrisi, Charles E., Lapin, Jeanne, Palmer, Leah N., Weinstein, Sharon M., Portenoy, Russell K.

“…Objectives: (1) To assess the feasibility and tolerability of the therapeutic transdermal fentanyl system (TTS-fentanyl) by using a clinical protocol developed…”
Get full text

Topotecan combined with myeloablative doses of thiotepa and carboplatin for neuroblastoma, brain tumors, and other poor-risk solid tumors in children and young adults by KUSHNER, B. H, CHEUNG, N.-Kv, KRAMER, K, DUNKEL, I. J, CALLEJA, E, BOULAD, F

“…Topotecan appears to be relatively unaffected by the most common multidrug resistance mechanisms, may potentiate cytotoxicity of alkylators, has good…”
Get full text

High-dose carmustine, thiotepa and etoposide followed by autologous bone marrow rescue for the treatment of high risk central nervous system tumors by PAPADAKIS, V, DUNKEL, I. J, STRANDJORD, S, COCCIA, P, KAPLAN, A. M, KLEMPERER, M, FINLAY, J. L, CRAMER, L. D, KRAMER, E, PAPADOPOULOS, E, GOLDMAN, S, PACKER, R. J, WILLOUGHBY, M, BAKER, D, GARVIN, J

“…Forty-two patients (29 newly diagnosed) with high grade gliomas (n = 37), medulloblastoma (n = 2) or non-biopsied tumors (n = 3) with supratentorial (n = 24),…”
Get full text

Third (fourth and fifth) nonocular tumors in survivors of retinoblastoma by Abramson, D H, Melson, M R, Dunkel, I J, Frank, C M

“…This study aimed to investigate the incidence, timing, pattern, and distribution of, as well as survival as a result of, third, fourth, and fifth primary…”
Get more information